InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Hutt Peter Barton. Officer active across 1 company, notably Concert Pharmaceuticals, INC.. Cumulatively, 5 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €22k. Activity tracked since 14 October 2022. The latest transaction was disclosed on 14 October 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Hutt Peter Barton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
13,088 股Common StockSEC:0001209191-23-016165:0
3,539 股@ US$2.8832.1% 占其流量Common StockSEC:0001209191-22-053967:0
3,539 股@ US$6.0967.9% 占其流量Common StockSEC:0001209191-22-053967:1
16,400 股Common StockSEC:0001209191-22-036288:0
5,125 股Common StockSEC:0001209191-21-039746:0
5 条申报中的 5 条
About Hutt Peter Barton
HUTT PETER BARTON is a declarant linked to Concert Pharmaceuticals, INC., where he is a Director. Across 6 filings in total, the 6 sampled filings run from 2021-06-11 to 2023-03-06 and show EUR 0 of purchases and EUR 22102 of sales, with the modal transaction nature listed as Attribution.
